Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

LPG SYSTEMS Unveils a Major Advancement: Irradiated Mastectomy Patients Can Benefit From Minimally Invasive Breast Reconstruction
  • USA - Français
  • Brazil - Português
  • USA - Deutsch
  • USA - español
  • Latin America - español
  • USA - English


News provided by

LPG Systems

09 Dec, 2019, 14:30 IST

Share this article

Share toX

Share this article

Share toX

NICE, France, Dec. 9, 2019 /PRNewswire/ -- A pilot study published in the Breast Journal shows the benefits of using Endermologie - a trademark of LPG SYSTEMS - in breast reconstruction after mastectomy and radiotherapy. This study included 65 women that had breast reconstruction with lipofilling +/- prothesis placement. These patients chose not to undergo flap-based reconstruction or had contraindications to the procedure and 33 of them benefited from Endermologie before the reconstructive procedures to prepare irradiated skin. The volume of fat injected was significantly superior in the Endermologie group compared with the controls for the first and second lipofilling (259.3 mL vs 150.6 mL and 251.8 mL vs 154 mL, respectively) and complications are minimized (3% vs 12.5%). Six patients in the Endermologie group had lipofilling alone (3 sessions). Authors propose that Endermologie could impact the quality of cutaneous and subcutaneous tissue resulting in improved surgical and cosmetic outcome. Patients without Endermologie treatment displayed signs of low skin trophicity such as vessel dilatation, thin skin, and capsular retraction while patients with Endermologie treatment displayed improved skin trophicity possibly leading to better long-term outcome of the lipofilling process. Endermologie might impact the biology of the irradiated tissue and hence initiate an appropriate regenerative niche. If confirmed in a prospective study, Endermologie could become a standard in patients' preparation for lipofilling‐based reconstruction. 

LPG SYSTEMS is a world leader in cellular regeneration through mechanostimulation with its patented technologies for health, beauty and well-being.

To download the abstract of the article: https://onlinelibrary.wiley.com/doi/abs/10.1111/tbj.13645 

Logo - https://mma.prnewswire.com/media/1041259/LPG_medical_Logo.jpg  
Logo - https://mma.prnewswire.com/media/1041260/IDS_Logo.jpg

Contact:
MONTEUX Clelia,
[email protected]
+33-(0)4-92-38-39-00

Related Links

https://www.lpgsystems.com/

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.